Naoya Kakutani Selected Research

6,10- diaza- 3(1,3),8(1,4)dibenzena- 1,5(1,4)diquinolinacyclodecaphane

1/2018

Small-conductance Ca2+-activated K+ channel activation deteriorates hypoxic ventricular arrhythmias via CaMKII in cardiac hypertrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naoya Kakutani Research Topics

Disease

12	Heart Failure 01/2021 - 10/2018
6	Myocardial Infarction 01/2021 - 10/2018
2	Fibrosis (Cirrhosis) 01/2021 - 01/2020
2	Body Weight (Weight, Body) 01/2021 - 01/2020
2	Cardiotoxicity 01/2021 - 12/2020
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Left Ventricular Dysfunction 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2020
1	Muscular Atrophy (Muscle Atrophy) 06/2020
1	Atrophy 06/2020
1	Hypertrophy 01/2020
1	Inflammation (Inflammations) 01/2020
1	Necrosis 01/2020
1	Anemia 01/2020
1	Hypoxia (Hypoxemia) 01/2018
1	Cardiomegaly (Heart Hypertrophy) 01/2018
1	Dehydration (Water Stress) 01/2016

Drug/Important Bio-Agent (IBA)

3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 10/2018
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 10/2018
3	salicylhydroxamic acid (SHAM)IBA 01/2021 - 10/2018
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 01/2020
2	CollagenIBA 01/2021 - 01/2020
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021 - 01/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 12/2020
2	Angiotensin IIIBA 06/2020 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 06/2020 - 10/2018
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	Febuxostat FDA Link 01/2021
1	Pioglitazone (Actos)FDA Link 01/2021
1	Adenosine Monophosphate (AMP)IBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	Streptozocin (Streptozotocin)FDA Link 01/2021
1	Xanthine OxidaseIBA 01/2021
1	alpha-galactosylceramideIBA 12/2020
1	TOR Serine-Threonine KinasesIBA 06/2020
1	Branched-Chain Amino AcidsIBA 06/2020
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2020
1	empagliflozinIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2020
1	Mitogen-Activated Protein KinasesIBA 01/2020
1	C.I. direct red 80IBA 01/2020
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2020
1	CytokinesIBA 01/2020
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Lisinopril (Prinivil)FDA LinkGeneric 01/2020
1	Drinking WaterIBA 01/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020
1	Cardiolipins (Cardiolipin)IBA 10/2019
1	Linoleic Acid (Linoleate)IBA 10/2019
1	Oxygen (Dioxygen)IBA 10/2018
1	6,10- diaza- 3(1,3),8(1,4)dibenzena- 1,5(1,4)diquinolinacyclodecaphaneIBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2018
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 01/2018
1	ApaminIBA 01/2018
1	Pesticide Residues (Pesticide Residue)IBA 01/2016
1	acetonitrileIBA 01/2016

Therapy/Procedure

2	Early Ambulation 04/2020 - 02/2019
1	Premedication 01/2021
1	Length of Stay 02/2019